Abstract
The Corona Virus Disease 2019 (COVID-19) pandemic caused by novel coronavirus primarily causing infection of lower respiratory tract since December 2019 has been leading cause of mortality and morbidity. With this unpredicted health emergency the number of ischemia related health events has also seen sudden rise, be it cardiovascular disease, stroke, acute limb ischemia and acute thrombo-embolic arterial and venous insult to the gastrointestinal system [1,2]. Acute thrombo-embolic occlusion of the Superior Mesenteric Artery (SMA) is uncommon condition with high mortality rates. High Mortality rate can be attributed to low preoperative diagnostic accuracy and limited timely therapeutic options [3]. The mode of diagnosis has shifted from autopsy to laparotomy and multidetector computer tomography in last couple of decades. Nonocclusive mesenteric ischemia (NOMI) leading to transmural intestinal infraction is a condition with extremely high mortality. Despite the considerable advances in the diagnosis and treatment, cause of mesenteric ischemic by enlarge remains elusive. This case series is aimed to provide valuable insight into to presentation ad outcome during COVID.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
